Intravenous bisphosphonates for postmenopausal osteoporosis

Numerous clinical studies have shown bisphoshonates (BPs) to be useful and cost-effective options for the fractures prevention and postmenopausal bone loss. The use of oral bisphoshonates is an established option for managment of osteoporosis in postmenopausal women, but many of them complaint from...

Full description

Bibliographic Details
Main Author: Peyman Mottaghi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2010-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2010;volume=15;issue=3;spage=175;epage=184;aulast=Mottaghi